Revinty Ellipta
- Licence status
- Active substances
- Fluticasone furoate, Vilanterol
- Dosage Form
- Inhalation powder, pre-dispensed
- Licence number
- EU/1/14/929/004-006
- Licence holder
- GlaxoSmithKline (Ireland) Limited
Product documents
Licence information
- ATC code
- R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics, R03AK10 vilanterol and fluticasone furoate
- Route of supply
- Product subject to prescription which may be renewed (B)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 17/06/2014
Stay updated: document advice
The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie